Panakes Partners

We are a Venture Capital firm founded by leading experts in the fields of science, technology, medicine, business, and finance. We are initially focused on global medical technology. With over 40 patents and multiple successful ventures amongst the founders, we have a proven track record of astute medical and technology investment management. We don't just invest, we build, nurture and curate our community of ventures to be the best they can. We believe that with an increasing global population, an aging and ailing population in developed economies and with increases in non-communicable diseases, there exists a unique opportunity for investors to capitalise on high growth medical technology and life sciences that will not only drive high returns for investors but make the world a better place through improved quality of life.

Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. Impact: We want to push the boundaries of science and medicine improving patient’s life Disruptive: We look for highly innovative and transformative technologies Hands-on: We consider ourselves partners and collaborators to our portfolio companies

Biospring Partners was founded in 2020 to invest in companies with the potential to fundamentally shift how technology is utilized across the life sciences sector. Michelle Dipp and Jennifer Lum came together to combine their experience in healthcare, technology, investing and operations to offer a differentiated approach to growth equity. Expanding the potential of life sciences technology We focus on identifying long-term themes within life sciences technology. We build trusted partnerships with management teams to support the growth of their businesses. Sectors we invest in Biospring invests in growth-stage B2B companies that are driving innovation across the life sciences industry and beyond. Our Approach We are a trusted partner that thrives in building long term strategic partnerships. We work closely alongside our companies to broaden their ambition and strengthen their path to growth. Our Investment Criteria$10M+ in annual revenue 30%+ revenue growth Diverse customer base

라플라스파트너스는 초기 단계 기술 기업들의 성장을 돕는 것을 소명으로 여기며, 시장을 확장하는 등 강한 목적의식을 가진 스타트업들과 협력하고 싶습니다. 비전 어떤 문제를 해결하고 세상에 어떤 변화를 가져오고 싶은지, 즉, 미래에 대한 명확한 비전을 그릴 수 있는 팀을 기대합니다. 이유 세상의 많은 문제들 중 왜 ‘그 문제’를 해결하고 싶은지에 대해 납득할 만한 이유가 있는 팀을 선호합니다 가치 ‘비전’과 ‘이유’를 바탕으로 고객에게 얼마나 유의미한 가치를 제공할 수 있는가에 집중합니다. 혁신 기술 라플라스파트너스는 혁신 기술로 문제를 해결하고 새로운 패러다임을 만들어가는 영역에 투자합니다. 바이오·헬스케어 제약, 혁신 진단 기기, 디지털 헬스케어, 건강 기능 식품, 푸드테크 등 소재·부품·장비 2차 전지, 반도체 소재·장비, 에너지, 신소재, 디스플레이, 통신 등 IT 인공지능(AI)의 응용, 전기차, 자율주행, 로봇, 메타버스, 증강현실(AR) 등

Wellington Partners is a leading European venture capital firm supporting outstanding entrepreneurs and their products on their way to market leadership. We have already invested in more than 50 early- and growth-stage life science companies, active in the fields of biotechnology, therapeutics, medical devices, diagnostics and digital health. We do not only provide financial resources, but also contribute our expertise, hard work and passion to help world class teams in building successful businesses of exceptional growth. Working hand in hand with our portfolio companies, we turn big ideas into big successes. We provide world class entrepreneurs with the capital for the financing of breakthrough products with the potential to decisively improve current standard of care and, most importantly, the lives of patients. We proactively source deals and lead or co-lead financing rounds, from early stage to expansion stage and selected PIPE investments (Private Investment in Public Equity). Our ticket sizes typically range from EUR 2 million to EUR 20 million. All-round support for all stages of growth Providing funding is only one part of our business, with long-term commitment and active collaboration being the other. Our team consists of both MDs and PhDs and brings together a unique combination of passionate and committed people, extensive investment experience and company-building skills. Our role is to offer board level strategic support to entrepreneurs while they exercise operational control. Together with our global scientific and commercial network, we are in a position to organize financing rounds, accelerate preclinical and clinical development, regulatory approval processes, and drive successful market entry into the most important healthcare markets in Europe, the U.S. and Asia. Successful exits We know that success does not happen overnight and we are prepared to accompany entrepreneurs for as long as it might take to transform great ideas into great successes and ultimately deliver outstanding results for those we serve – patients, entrepreneurs, and the people and organizations that entrust us with their capital. More than 20 of our portfolio companies have already achieved a successful exit or IPO. Here are a few examples: Definiens Rigontec Themis Bioscience Invendo medical Sapiens Atopix Therapeutics Oxford Immunotec MTM Laboratories

Luma Group is passionately leading a transformation in healthcare, driven by a deep-seated commitment to enhance human health. We’re on a mission to turn visionary science into revolutionary healthcare solutions. Our team unites a dynamic mix of investors, scientists, clinicians, and entrepreneurs, all dedicated to advancing human health outcomes. We are not just funding remarkable scientific discoveries; we are investing in the future of humanity. Our focus is on nurturing groundbreaking innovations leveraging advanced computation and artificial intelligence that promise to redefine healthcare, ensuring that every investment we make contributes to a healthier, brighter future for all. Our approach is hands-on and collaborative, partnering with the brightest minds in science, clinical research, engineering, and entrepreneurship. We’re not just investors; we’re co-creators, working side-by-side with innovators and dreamers to transform cutting-edge scientific discoveries into groundbreaking therapeutics, diagnostics, and medical devices. Our goal is clear: to make a significant and lasting impact on human health. Every project we embark on is a step towards redefining what’s possible in healthcare, ensuring that we’re not just part of the conversation, but leading the charge in creating a healthier future for everyone.